Pirfenidone 267mg tablets
NHS hospitals in England used £20,210,282 of indicative cost of Pirfenidone 267mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 13.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Pirfenidone 267mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Pirfenidone 267mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £4,139,061 |
| Manchester University Nhs Ft | £3,957,593 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,788,214 |
| Oxford University Hospitals Nhs Ft | £1,644,076 |
| Royal Papworth Hospital Nhs Ft | £1,353,861 |
| Nottingham University Hospitals Trust | £943,669 |
| Aintree University Hospital Nhs Ft | £902,118 |
| North Bristol Nhs Trust | £850,206 |
| Sheffield Teaching Hospitals Nhs Trust | £642,245 |
| Norfolk & Norwich University Hpl Nhs Trt | £490,772 |
The primary-care picture
Pirfenidone is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Pirfenidone medicine page.